Compare LSAK & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LSAK | SOPH |
|---|---|---|
| Founded | 1997 | 2011 |
| Country | South Africa | Switzerland |
| Employees | 3728 | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 386.0M | 330.4M |
| IPO Year | N/A | 2021 |
| Metric | LSAK | SOPH |
|---|---|---|
| Price | $4.67 | $4.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 38.6K | ★ 56.4K |
| Earning Date | 02-04-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $677,582,000.00 | $73,297,000.00 |
| Revenue This Year | $11.97 | $18.32 |
| Revenue Next Year | $9.14 | $15.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.48 | 13.66 |
| 52 Week Low | $3.39 | $2.58 |
| 52 Week High | $5.55 | $5.30 |
| Indicator | LSAK | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 62.45 | 50.54 |
| Support Level | $4.27 | $4.56 |
| Resistance Level | $4.49 | $4.82 |
| Average True Range (ATR) | 0.19 | 0.18 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 59.42 | 42.41 |
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates three reportable segments: Merchant, Consumer and Enterprise. Merchant, which focuses on both formal and informal sector merchants. Consumer, which focuses on individuals who have historically been excluded from traditional financial services and to whom it offers transactional accounts (banking), insurance, lending (short-term loans), payments solutions and various value-added services; and Enterprise, which comprises large-scale corporate and government organizations, including but not limited to banks, mobile network operators (MNOs) and municipalities, and, through Recharger, landlords utilizing Recharger's prepaid electricity metering solution.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.